Pharmacokinetics Services Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Pharmacokinetics Services market is expected to grow at a CAGR of 4.9% during the forecast period.
The global Pharmacokinetics Services market is estimated to be about 562.3 million US dollars in 2020.
The global Pharmacokinetics Services market is estimated to reach 680.3 million USD by 2026.
The global Pharmacokinetics Services market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Pharmacokinetics Services market will be able to gain an advantage as they use reports as a powerful resource.
Pharmacokinetics Services markets by category
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Pharmacokinetics Services Market by Application (Percentage of Demand)
Small & Medium Enterprise
Large Enterprise
Who are the leading companies in Pharmacokinetics Services
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
Pharmacokinetics Services markets by region:
In North America
In Latin America
Europe
The Asia-pacific
Middle East and Africa (MEA)
What are the main countries covered
The United States
Canada
Germany
France
UK
Italy
Russia
China
Japan
Korea
Southeast Asia
India
Australia
Brazil
Mexico
Argentina
Chile
Colombia
Egypt
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Which is the most profitable market
Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Pharmacokinetics Services.
What methodology did you follow in your research
This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.
Who were the primary study respondents
We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.
What are the sources of secondary research
We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Market Size Units
1.8 Review Cycle
2 Global Market Overview
2.1 Global Pharmacokinetics Services Revenue and Growth Forecast 2014-2026
2.2 Global Pharmacokinetics Services Market Size and Growth Forecast 2014-2026
2.3 Global Pharmacokinetics Services Revenue by Region 2014-2026
2.4 Pharmacokinetics Services Market Share by Major Regions 2014-2021
2.5 Pharmacokinetics Services Gross Margin in Different Region 2014-2021
2.6 Global Pharmacokinetics Services Market History Price and Forecast 2014-2026
2.7 Global Pharmacokinetics Services Sales Market Share by Top Companies 2014-2021
3 Global Pharmacokinetics Services Market by Type
3.1 Global Pharmacokinetics Services Revenue and Growth Rate Segment by Types from 2014-2021
3.2 Global Pharmacokinetics Services Market Size and Growth Rate Segment by Product Types from 2014-2021
3.3 Global Pharmacokinetics Services Price Segment by Types from 2014-2021
3.4 Brief Introduction of Different Types
3.4.1 Small Molecules Pharmacokinetics Services
3.4.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
4 Global Pharmacokinetics Services Market by Application
4.1 Global Pharmacokinetics Services Revenue and Growth Rate Segment by Applications from 2014-2021
4.2 Global Pharmacokinetics Services Market Size and Growth Rate Segment by Product Applications from 2014-2021
4.3 Brief Introduction of Different Applications
4.3.1 Small & Medium Enterprise
4.3.2 Large Enterprise
5 North America Pharmacokinetics Services Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
5.1 North America Pharmacokinetics Services Value ($) from 2014-2021
5.2 North America Pharmacokinetics Services Market Size from 2014-2021
5.3 North America Pharmacokinetics Services Price Change from 2014-2021
5.4 North America Pharmacokinetics Services Import and Export from 2014-2021
5.5 North America Pharmacokinetics Services Market Value ($) and Growth (%) by Type from 2014-2021
5.6 North America Pharmacokinetics Services Market Value ($) and Growth (%) by Application from 2014-2021
5.7 North America Pharmacokinetics Services Market Value ($) and Growth (%) by Countries from 2014-2021
5.7.1 The United States
5.7.2 Canada
5.8 Top North America Pharmacokinetics Services Participants Value ($) and Market Share (%) in 2020
6 Europe Pharmacokinetics Services Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
6.1 Europe Pharmacokinetics Services Value ($) from 2014-2021
6.2 Europe Pharmacokinetics Services Market Size from 2014-2021
6.3 Europe Pharmacokinetics Services Price Change from 2014-2021
6.4 Europe Pharmacokinetics Services Import and Export from 2014-2021
6.5 Europe Pharmacokinetics Services Market Value ($) and Growth (%) by Type from 2014-2021
6.6 Europe Pharmacokinetics Services Market Value ($) and Growth (%) by Application from 2014-2021
6.7 Europe Pharmacokinetics Services Market Value ($) and Growth (%) by Countries from 2014-2021
6.7.1 Germany
6.7.2 France
6.7.3 UK
6.7.4 Italy
6.7.5 Russia
…
6.8 Top Europe Pharmacokinetics Services Participants Value ($) and Market Share (%) in 2020
7 Asia-Pacific Pharmacokinetics Services Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
7.1 Asia-Pacific Pharmacokinetics Services Value ($) from 2014-2021
7.2 Asia-Pacific Pharmacokinetics Services Market Size from 2014-2021
7.3 Asia-Pacific Pharmacokinetics Services Price Change from 2014-2021
7.4 Asia-Pacific Pharmacokinetics Services Import and Export from 2014-2021
7.5 Asia-Pacific Pharmacokinetics Services Market Value ($) and Growth (%) by Type from 2014-2021
7.6 Asia-Pacific Pharmacokinetics Services Market Value ($) and Growth (%) by Application from 2014-2021
7.7 Asia-Pacific Pharmacokinetics Services Market Value ($) and Growth (%) by Countries from 2014-2021
7.7.1 China
7.7.2 Japan
7.7.3 Korea
7.7.4 Southeast Asia
7.7.5 India
7.7.6 Australia
…
7.8 Top Asia-Pacific Pharmacokinetics Services Participants Value ($) and Market Share (%) in 2020
8 Latin America Pharmacokinetics Services Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
8.1 Latin America Pharmacokinetics Services Value ($) from 2014-2021
8.2 Latin America Pharmacokinetics Services Market Size from 2014-2021
8.3 Latin America Pharmacokinetics Services Price Change from 2014-2021
8.4 Latin America Pharmacokinetics Services Import and Export from 2014-2021
8.5 Latin America Pharmacokinetics Services Market Value ($) and Growth (%) by Type from 2014-2021
8.6 Latin America Pharmacokinetics Services Market Value ($) and Growth (%) by Application from 2014-2021
8.7 Latin America Pharmacokinetics Services Market Value ($) and Growth (%) by Countries from 2014-2021
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Chile
8.7.5 Colombia
…
8.8 Top Latin America Pharmacokinetics Services Participants Value ($) and Market Share (%) in 2020
9 Middle East & Africa Pharmacokinetics Services Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
9.1 Middle East & Africa Pharmacokinetics Services Value ($) from 2014-2021
9.2 Middle East & Africa Pharmacokinetics Services Market Size from 2014-2021
9.3 Middle East & Africa Pharmacokinetics Services Price Change from 2014-2021
9.4 Middle East & Africa Pharmacokinetics Services Import and Export from 2014-2021
9.5 Middle East & Africa Pharmacokinetics Services Market Value ($) and Growth (%) by Type from 2014-2021
9.6 Middle East & Africa Pharmacokinetics Services Market Value ($) and Growth (%) by Application from 2014-2021
9.7 Middle East & Africa Pharmacokinetics Services Market Value ($) and Growth (%) by Countries from 2014-2021
9.7.1 Egypt
9.7.2 Saudi Arabia
9.7.3 United Arab Emirates
9.7.4 Nigeria
9.7.5 South Africa
…
9.8 Top Middle East & Africa Pharmacokinetics Services Participants Value ($) and Market Share (%) in 2020
10. Global Level Competitive Intelligence – Company Profiles
10.1 Evotec AG (Germany)
10.1.1 Evotec AG (Germany) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.1.2 Evotec AG (Germany) Sales, Value, Gross and Gross Margin from 2014-2021
10.1.3 Evotec AG (Germany) Value and Growth Change from 2014-2021
10.1.4 Evotec AG (Germany) Price Change from 2014-2021
10.1.5 Evotec AG (Germany) Product Offered
10.2 Pacific BioLabs (US)
10.2.1 Pacific BioLabs (US) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.2.2 Pacific BioLabs (US) Sales, Value, Gross and Gross Margin from 2014-2021
10.2.3 Pacific BioLabs (US) Value and Growth Change from 2014-2021
10.2.4 Pacific BioLabs (US) Price Change from 2014-2021
10.2.5 Pacific BioLabs (US) Product Offered
10.3 GVK Biosciences Private Limited (India)
10.3.1 GVK Biosciences Private Limited (India) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.3.2 GVK Biosciences Private Limited (India) Sales, Value, Gross and Gross Margin from 2014-2021
10.3.3 GVK Biosciences Private Limited (India) Value and Growth Change from 2014-2021
10.3.4 GVK Biosciences Private Limited (India) Price Change from 2014-2021
10.3.5 GVK Biosciences Private Limited (India) Product Offered
10.4 Shanghai Medicilon Inc. (China)
10.4.1 Shanghai Medicilon Inc. (China) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.4.2 Shanghai Medicilon Inc. (China) Sales, Value, Gross and Gross Margin from 2014-2021
10.4.3 Shanghai Medicilon Inc. (China) Value and Growth Change from 2014-2021
10.4.4 Shanghai Medicilon Inc. (China) Price Change from 2014-2021
10.4.5 Shanghai Medicilon Inc. (China) Product Offered
10.5 Pharmaceutical Product Development, LLC (US)
10.5.1 Pharmaceutical Product Development, LLC (US) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.5.2 Pharmaceutical Product Development, LLC (US) Sales, Value, Gross and Gross Margin from 2014-2021
10.5.3 Pharmaceutical Product Development, LLC (US) Value and Growth Change from 2014-2021
10.5.4 Pharmaceutical Product Development, LLC (US) Price Change from 2014-2021
10.5.5 Pharmaceutical Product Development, LLC (US) Product Offered
10.6 Charles River Laboratories International, Inc. (US)
10.6.1 Charles River Laboratories International, Inc. (US) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.6.2 Charles River Laboratories International, Inc. (US) Sales, Value, Gross and Gross Margin from 2014-2021
10.6.3 Charles River Laboratories International, Inc. (US) Value and Growth Change from 2014-2021
10.6.4 Charles River Laboratories International, Inc. (US) Price Change from 2014-2021
10.6.5 Charles River Laboratories International, Inc. (US) Product Offered
10.7 PAREXEL International Corporation (US)
10.7.1 PAREXEL International Corporation (US) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.7.2 PAREXEL International Corporation (US) Sales, Value, Gross and Gross Margin from 2014-2021
10.7.3 PAREXEL International Corporation (US) Value and Growth Change from 2014-2021
10.7.4 PAREXEL International Corporation (US) Price Change from 2014-2021
10.7.5 PAREXEL International Corporation (US) Product Offered
10.8 Eurofins Scientific, Inc. (Luxembourg)
10.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.8.2 Eurofins Scientific, Inc. (Luxembourg) Sales, Value, Gross and Gross Margin from 2014-2021
10.8.3 Eurofins Scientific, Inc. (Luxembourg) Value and Growth Change from 2014-2021
10.8.4 Eurofins Scientific, Inc. (Luxembourg) Price Change from 2014-2021
10.8.5 Eurofins Scientific, Inc. (Luxembourg) Product Offered
10.9 Frontage Labs (US)
10.9.1 Frontage Labs (US) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.9.2 Frontage Labs (US) Sales, Value, Gross and Gross Margin from 2014-2021
10.9.3 Frontage Labs (US) Value and Growth Change from 2014-2021
10.9.4 Frontage Labs (US) Price Change from 2014-2021
10.9.5 Frontage Labs (US) Product Offered
10.10 SGS SA (Switzerland)
10.10.1 SGS SA (Switzerland) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.10.2 SGS SA (Switzerland) Sales, Value, Gross and Gross Margin from 2014-2021
10.10.3 SGS SA (Switzerland) Value and Growth Change from 2014-2021
10.10.4 SGS SA (Switzerland) Price Change from 2014-2021
10.10.5 SGS SA (Switzerland) Product Offered
10.11 LGC Limited (UK)
10.11.1 LGC Limited (UK) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.11.2 LGC Limited (UK) Sales, Value, Gross and Gross Margin from 2014-2021
10.11.3 LGC Limited (UK) Value and Growth Change from 2014-2021
10.11.4 LGC Limited (UK) Price Change from 2014-2021
10.11.5 LGC Limited (UK) Product Offered
10.12 Creative Bioarray (US)
10.12.1 Creative Bioarray (US) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.12.2 Creative Bioarray (US) Sales, Value, Gross and Gross Margin from 2014-2021
10.12.3 Creative Bioarray (US) Value and Growth Change from 2014-2021
10.12.4 Creative Bioarray (US) Price Change from 2014-2021
10.12.5 Creative Bioarray (US) Product Offered
10.13 Certara, L.P. (Germany)
10.13.1 Certara, L.P. (Germany) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.13.2 Certara, L.P. (Germany) Sales, Value, Gross and Gross Margin from 2014-2021
10.13.3 Certara, L.P. (Germany) Value and Growth Change from 2014-2021
10.13.4 Certara, L.P. (Germany) Price Change from 2014-2021
10.13.5 Certara, L.P. (Germany) Product Offered
11. Market Dynamics
11.1 Driving Factors
11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …
11.1.2 Increasing Use of Pharmacokinetics Services by Different End-User/Applications
11.2 Restraints and Challenges in the Market
11.3 Opportunities
11.4 Covid-19 Impact/Evaluation
12. Future Forecast of Global Pharmacokinetics Services Market from 2020-2026
12.1 Future Forecast of Global Pharmacokinetics Services Market from 2020-2026 Segment by Regions
12.2 Future Forecast of Global Pharmacokinetics Services Market from 2020-2026 Segment by Type
12.3 Future Forecast of Global Pharmacokinetics Services Market from 2020-2026 Segment by Application
13. Investment Analysis
13.1 Fundamental Analysis (Porter's Five Forces Analysis)
13.2 Technical Preparation Analysis
13.3 Risk Evaluating Analysis
13.4 Estimated Investment Pay-Back Period
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.2 Primary Data
14.2 Revenue Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach (Involves time, Space, and Persons)
14.3 Data Triangulation
14.4 Assumptions
14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
14.6 Limitations of Our Study
14.7 Scene Based Modeling
15 Disclaimer
Research Methodology:
Pharmacokinetics Services Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|